Search Results

You are looking at 11 - 20 of 125 items for

  • Refine by Access: All content x
Clear All Modify Search
Open access

Bliss Anderson and Daniel L Morganstein

practice is to reserve high dose corticosteroids for those presenting with adrenal crisis or with significant pituitary enlargement. Other patients can be commenced directly on replacement doses of corticosteroids (e.g. hydrocortisone 20 mg daily in divided

Open access

Hanna F Nowotny, Jillian Bryce, Salma R Ali, Roberta Giordano, Federico Baronio, Irina Chifu, Lea Tschaidse, Martine Cools, Erica LT van den Akker, Henrik Falhammar, Natasha M Appelman-Dijkstra, Luca Persani, Guglielmo Beccuti, Ian L Ross, Simona Grozinsky-Glasberg, Alberto M Pereira, Eystein S Husebye, Stefanie Hahner, S Faisal Ahmed, and Nicole Reisch

stress-related cortisol rise by the interference of antibodies directed against those viral antigens with the host’s natural secretion of corticosteroids ( 8 ). Recent studies in patients with SARS-CoV-2 infections confirmed significantly impaired

Open access

Pablo Abellán-Galiana, Carmen Fajardo-Montañana, Pedro Riesgo-Suárez, Marcelino Pérez-Bermejo, Celia Ríos-Pérez, and José Gómez-Vela

specific treatment for hypercortisolism (ketoconazole and/or cabergoline) was suspended before surgery (at least 1 week), avoiding the use of corticosteroids in the surgical phase. Imaging studies using neuronavigation protocols were made, together with a

Open access

L Ghataore, I Chakraborti, S J Aylwin, K-M Schulte, D Dworakowska, P Coskeran, and N F Taylor

cortisol due to rapid conversion by CYP3A4 in the liver, perhaps during a first pass after adsorption from the gut. A second factor may be an increase in corticosteroid binding globulin during mitotane treatment (23) . Induction of CYP3A4 by mitotane needs

Open access

Anne-Sophie C A M Koning, Philippe C Habets, Marit Bogaards, Jan Kroon, Hanneke M van Santen, Judith M de Bont, and Onno C Meijer

presence of both GR and MR in dexamethasone-exposed human hippocampal tissue We next visualized the subcellular distribution of the corticosteroid receptors in the human hippocampus. As expected, IF staining of GR in the dexamethasone-treated tissue

Open access

Xiaowen Zhang, Chen Han, Hongwei Wang, Xinghong Sun, Xin Dou, Xueying He, Di Wu, Shanmei Shen, Dalong Zhu, Xinlin Zhang, and Yan Bi

corticosteroid treatment could impact NLR values and MR findings, we performed a separate analysis excluding those who were receiving or have received corticosteroid treatments over 3 months before enrollment. A Cox proportional hazards model was used to identify

Open access

Jan Calissendorff and Henrik Falhammar

with adjunctive therapy as cholestyramine or corticosteroids was not used. Figure 1 Accumulative doses of iodine solution in 27 patients with uncontrolled Graves’ disease. Background information and side effects necessitating treatment

Open access

Sophie Howarth, Luca Giovanelli, Catherine Napier, and Simon H Pearce

Metabolism 2014 99 111 – 118 . ( https://doi.org/10.1210/JC.2013-2449 ) 13 Vulto A Bergthorsdottir R Faassen van M Kema IP Johannsson G van Beek AP . Residual endogenous corticosteroid production in patients with adrenal insufficiency

Open access

Annelies van’t Westeinde, Leif Karlsson, Valeria Messina, Lena Wallensteen, Manuela Brösamle, Giorgio Dal Maso, Alessandro Lazzerini, Jette Kristensen, Diana Kwast, Lea Tschaidse, Matthias K Auer, Hanna F Nowotny, Luca Persani, Nicole Reisch, and Svetlana Lajic

Endocrinology 2007 16 37 – 44 . ( https://doi.org/10.1297/cpe.16.37 ) 45 Bonanno C Wapner RJ . Antenatal corticosteroids in the management of preterm birth: are we back where we started? Obstetrics and Gynecology Clinics of North America 2012 39 47 – 63

Open access

R A M Quax, J A M van Laar, R van Heerebeek, K Greiner, E Ben-Chetrit, M Stanford, G R Wallace, F Fortune, M Ghabra, M Soylu, J M W Hazes, S W J Lamberts, J H Kappen, P M van Hagen, J W Koper, and R A Feelders

. A double-blind trial of depot corticosteroids in Behcet's syndrome . Rheumatology 2006 45 348 – 352 . ( doi:10.1093/rheumatology/kei165 ). 33 Barnes PJ Adcock IM . Glucocorticoid resistance in inflammatory diseases . Lancet 2009 373